PLA inhibits TNF-α-induced PANoptosis of prostate cancer cells through metabolic reprogramming
The International Journal of Biochemistry & Cell Biology · 2024
DOI: 10.1016/j.biocel.2024.106554 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2024. Verfasst von Yinghui Hao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, China. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Prostatic Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Previous studies have shown that phenyllactic acid (alpha-Hydroxyhydrocinnamic acid, 2-Hydroxy-3-phenylpropionic acid, PLA), a type of organic acid metabolite, has excellent diagnostic efficacy when used to differentiate between prostate cancer, benign prostatic hyperplasia, and prostatitis. This research aims to explore the molecular mechanism by which PLA influences the PANoptosis of prostate cancer (PCa) cell lines. First, we found that PLA was detected in all prostate cancer cell lines (PC-3, PC-3 M, DU145, LNCAP). Further experiments showed that the addition of PLA to prostate cancer cells could promote ATP generation, enhance cysteine desulfurase (NFS1) expression, and reduce tumor necrosis factor alpha (TNF-α) levels, thereby inhibiting apoptosis in prostate cancer cells. Notably, overexpression of NFS1 can inhibit the binding of TNF-α to serpin mRNA binding protein 1 (SERBP1), suggesting that NFS1 competes with TNF-α for binding to SERBP1. Knockdown of SERBP1 significantly reduced the level of small ubiquity-related modifier (SUMO) modification of TNF-α. This suggests that NFS1 reduces the SUMO modification of TNF-α by competing with SERBP1, thereby reducing the expression and stability of TNF-α and ultimately inhibiting apoptosis in prostate cancer cell lines. In conclusion, PLA inhibits TNF-α induced panapoptosis of prostate cancer cells through metabolic reprogramming, providing a new idea for targeted treatment of prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, China.
- Central Laboratory of Panyu Central Hospital, Guangzhou, China.
- Department of Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, China. Electronic address: doctoryuli@126.com.
- Central Laboratory of Panyu Central Hospital, Guangzhou, China. Electronic address: hanzeping1987@126.com.
- Department of Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, China; Central Laboratory of Panyu Central Hospital, Guangzhou, China; Rehabilitation Medicine Institu…
Zitieren
APA
Hao, Y., Xie, F., He, J., Gu, C., Zhao, Y., Luo, W., Song, X., Shen, J., Yu, L., Han, Z., & He, J. (2024). PLA inhibits TNF-α-induced PANoptosis of prostate cancer cells through metabolic reprogramming. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2024.106554
Vancouver
Hao Y, Xie F, He J, Gu C, Zhao Y, Luo W, et al. PLA inhibits TNF-α-induced PANoptosis of prostate cancer cells through metabolic reprogramming. The International Journal of Biochemistry & Cell Biology. 2024. doi:10.1016/j.biocel.2024.106554
BibTeX
@article{Hao2024,
author = {Hao, Yinghui and Xie, Fangmei and He, Jieyi and Gu, Chenqiong and Zhao, Ying and Luo, Wenfeng and Song, Xiaoyu and Shen, Jian and Yu, Li and Han, Zeping and He, Jinhua},
title = {PLA inhibits TNF-α-induced PANoptosis of prostate cancer cells through metabolic reprogramming},
journal = {The International Journal of Biochemistry & Cell Biology},
year = {2024},
doi = {10.1016/j.biocel.2024.106554}
}
EUVIMED